A short history of HIV and AIDS in Sweden, based on clips from the FoA archive.

Interview with David Cooper, Director of The Kirby Institute at the University of New South Wales.

XVII International AIDS Conference in Mexico City. Jeffrey Sturchio, Vice President of Merck & Co, talks about the development of protease inhibitors in 1996 and the relationship between the activists and the drug industry.

XVII International AIDS Conference in Mexico City. Jeffrey Sturchio, Vice President of Merck & Co, talks about the development of protease inhibitors in 1996 and the relationship between the activists and the drug industry.

Last part of the interview with the American AIDS activist and founder of Project Inform, Martin Delaney, in 2006. Here he talks about AIDS activism and the different stages of the antiretroviral drug development from AZT to triple combination treatment.